Zobrazeno 1 - 9
of 9
pro vyhledávání: '"E P, KELLEY"'
Autor:
E. Lynne Kelley, Richard H. Smith, Gillian Corcoran, Sandra Nygren, Mary V. Jacoski, Andrea Fernandes
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 1915-1922 (2021)
Needle-free injection is a desirable goal for many reasons, including reducing pain, anxiety, and eliminating safety risks associated with needle-stick injuries. However, development of a safe, reliable needle-free device optimized for at-home use ha
Externí odkaz:
https://doaj.org/article/ccec6f02949d4d7d8bfde4fe215df9e2
Publikováno v:
Frontiers in Toxicology, Vol 4 (2022)
Placental health is critical to fetal growth and maternal health during gestation. However, investigating placental flow in an ex-vivo isolated system where inflow is independently controlled has yet to be developed in the rat. Here, we describe a no
Externí odkaz:
https://doaj.org/article/7bc659bb684b4f6da757f6b4c2436103
Autor:
Lincoln R. Sheets, Laura E. Henderson Kelley, Kristen Scheitler-Ring, Gregory F. Petroski, Yan Barnett, Chris Barnett, Amy J.H. Kind, Jerry C. Parker
Publikováno v:
Preventive Medicine Reports, Vol 18, Iss , Pp - (2020)
Neighborhood context impacts health. Using an index of geospatial disadvantage measures to predict neighborhood socioeconomic disparities would support area-based allocation of preventative resources, as well as the use of location as a clinical risk
Externí odkaz:
https://doaj.org/article/6dd2d11b7f034e8ebc71723f9c0f255b
Autor:
R J, Derick, A L, Robin, T R, Walters, H S, Barnebey, N, Choplin, J, Schuman, E P, Kelley, K, Chen, J F, Stoecker
Publikováno v:
Ophthalmology. 104(1)
Brimonidine tartrate is a relatively selective alpha2-agonist that effectively reduces mean intraocular pressure (IOP) and the incidence of IOP spikes after laser trabeculoplasty. The authors were interested in evaluating the dose response of brimoni
Autor:
R J, Derick, A L, Robin, J, Tielsch, J L, Wexler, E P, Kelley, J F, Stoecker, G D, Novack, A L, Coleman
Publikováno v:
Ophthalmology. 99(3)
The authors executed a two-period, randomized, double-masked, crossover study comparing once-daily to twice-daily levobunolol hydrochloride (0.5%) in 20 patients with elevated intraocular pressure (IOP). Modified diurnal curves were performed at four
Autor:
S I, Rakofsky, M, Lazar, Y, Almog, R P, LeBlanc, C, Mann, A, Orr, P F, Lee, B R, Friedland, G D, Novack, E P, Kelley
Publikováno v:
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 24(1)
We studied the ocular hypotensive efficacy and safety of 0.5% levobunolol hydrochloride and 0.5% timolol maleate administered topically once daily for 3 months in 91 patients (46 in the levobunolol group and 45 in the timolol group) with primary or s
Autor:
E P, Kelley
Publikováno v:
JAMA. 206(3)
Autor:
E P, KELLEY
Publikováno v:
The Journal of the Florida Medical Association. Florida Medical Association. 40(4)
Autor:
Tamura, Tsunenobu, W. Andrews, William, E. Johnston, Kelley, Philamon Hemstreet, G., L. Goldenberg, Robert
Publikováno v:
Infectious Diseases in Obstetrics & Gynecology; 1997, Vol. 5 Issue: 1